An initiative by BeatO — India's diabetes and metabolic health platform

Cost & Savings Estimator

Indicative monthly pricing for GLP-1 medicines in India across starting, mid, and maintenance doses. These are educational ranges from publicly available prices — not quotes, and not a recommendation.

Medicine
Generic (e.g. Natco Semanat)
vials, starting dose
₹1,300–₹1,800
/ month
Generic pen brands
starting dose
₹1,600–₹2,200
/ month
Branded Ozempic
0.25–0.5 mg
₹8,800–₹9,500
/ month
Branded Wegovy
0.25 mg
₹5,660
/ month
Potential savings

Choosing Generic (e.g. Natco Semanat) over Branded Ozempic could save roughly 86% per month at this stage. Your doctor will confirm which option is clinically appropriate and available for you.

Prices shown are indicative, based on publicly available India pricing as of mid-2026, and change frequently as generics enter the market. This is not a quote, offer, or guarantee of price and does not constitute medical or purchasing advice. Actual cost depends on your prescribed dose and brand, as decided by your doctor.